Effective approaches to the treatment of patients with chronic hepatitis living in the Khorezm region

This study presents an assessment of the impact of various strategies for providing medical care to patients with chronic hepatitis (CH), on the prevalence of the disease, the incidence of adverse outcomes among residents of the Khorezm region. 61 patients with chronic hepatitis aged 16 to 60 years were examined. The use of the drug Heptral and diet No. 5 in combination with the generally accepted treatment contributes to the speedy improvement in well-being, an objective and laboratory diagnostic indicator, and an acceleration of the average stay in the hospital for patients with chronic hepatitis C living in the conditions of the South Aral Sea region.